You are here :
Home
Healthcare
Payment Link for Sterlitech Corporation - Track etched Membrane Market & Pharmaceutical Filtration Market
Drug formulations
Global Prostate Cancer Market Research Report
- Report Code: PR 1000
- Publish Date: Upcoming
Prostate Cancer can be segmented by Submarkets, Geographies and Companies. Submarkets of this market are Chromatography, E-Clinical Trial Solutions, Wireless Health, Clinical Trial Management Systems (CTMS), Healthcare IT outsourcing, Immunoassay, Digital Pathology, Chromatography Instruments, Next Generation Sequencing (NGS), Proteomics, Marketed Drugs (Prostate Cancer) and Pipeline Drugs (Prostate Cancer). Geographies of this market are Japan, India, Brazil, Russia, China, Turkey, Korea, Republic of (South Korea), Spain, Italy, USA, Canada, Germany, United Kingdom and France. Companies of this market are Sanofi-Aventis U.S., Abbott Laboratories, Dendreon Inc., AstraZeneca, Astellas Pharma Inc., Tolmar Inc. and Ipsen Group.
Key Questions Answered
- What are market estimates and forecasts; which of Prostate Cancer markets are doing well and which are not?
- What is the competitive landscape; How companies like Sanofi-Aventis U.S., Abbott Laboratories and Dendreon Inc. doing in Prostate Cancer?
- This reports provides most granular segmentation on Chromatography, E-Clinical Trial Solutions, Wireless Health and Clinical Trial Management Systems (CTMS).
- This report provides market sizing and forecast for the Prostate Cancer market. It also provides market sizing and forecast along with the drivers/inhibitors/opportunity analysis for each of the micro markets.
- The report provides deep dive competitive landscape covering the top players such as Sanofi-Aventis U.S., Abbott Laboratories, Dendreon Inc. and AstraZeneca.
- The reports provides benchmarking insight on the top players Sanofi-Aventis U.S., Abbott Laboratories, Dendreon Inc. and AstraZeneca.
- The report provide competitive intelligence on Sanofi-Aventis U.S., Abbott Laboratories, Dendreon Inc. and AstraZeneca.
- Global Prostate Cancer companies
- Manufacturing Companies
- Traders, distributors, and suppliers
- Governmental and research organizations
- Associations and industry bodies
- Technology providers
What makes our report unique?
Audience for this report
1 Introduction
1.1 Analyst Insights
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
2 Executive Summary
3 Market Overview
4 By Submarkets
4.1 Chromatography
4.2 E-Clinical Trial Solutions
4.3 Wireless Health
4.4 Clinical Trial Management Systems (CTMS)
4.5 Healthcare IT outsourcing
4.6 Immunoassay
4.7 Digital Pathology
4.8 Chromatography Instruments
4.9 Next Generation Sequencing (NGS)
4.10 Proteomics
4.11 Marketed Drugs (Prostate Cancer)
4.12 Pipeline Drugs (Prostate Cancer)
5 By Geographies
5.1 Japan
5.2 India
5.3 Brazil
5.4 Russia
5.5 China
5.6 Turkey
5.7 Korea, Republic of (South Korea)
5.8 Spain
5.9 Italy
5.10 USA
5.11 Canada
5.12 Germany
5.13 United Kingdom
5.14 France
6 By Companies
6.1 Sanofi-Aventis U.S.
6.2 Abbott Laboratories
6.3 Dendreon Inc.
6.4 AstraZeneca
6.5 Astellas Pharma Inc.
6.6 Tolmar Inc.
6.7 Ipsen Group
Please fill in the form below to receive a free copy of the Summary of this Report
Custom Market Research Services
We will customize the research for you, in case the report listed above does not
meet with your exact requirements. Our custom research will comprehensively cover
the business information you require to help you arrive at strategic and profitable
business decisions.
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
|
|
Hormonal Therapy (Pipeline Drugs) Hormonal Therapy (Pipeline Drugs) and its peer markets - Chromatography, |
Upcoming |
|
|
Targeted Therapy Targeted Therapy and its peer markets - Immunotherapy (Pipeline Drugs), |
Upcoming |
|
|
Immunotherapy (Pipeline Drugs) Immunotherapy (Pipeline Drugs) and its peer markets - Next Generation Sequencing (NGS), |
Upcoming |
|
|
Hormonal Therapy (Marketed drugs) Hormonal Therapy (Marketed drugs) and its peer markets - Chemotherapy, |
Upcoming |
|
|
Chemotherapy Chemotherapy and its peer markets - Immunoassay, Hormonal... |
Upcoming |
|
|
Immunotherapy (Marketed drugs) Immunotherapy (Marketed drugs) and its peer markets - Chromatography, |
Upcoming |
|
|
Lutienizing Hormone-Releasing Hormone (LHRH) Antagonists Lutienizing Hormone-Releasing Hormone (LHRH) Antagonists and Lutienizing Hormone-Releasing Hormone (LHRH) Analogs and |
Upcoming |
|
|
Lutienizing Hormone-Releasing Hormone (LHRH) Analogs Lutienizing Hormone-Releasing Hormone (LHRH) Analogs and Lutienizing Hormone-Releasing Hormone (LHRH) Antagonists and |
Upcoming |
|
|
Anti-Androgens Anti-Androgens and Lutienizing Hormone-Releasing Hormone (LHRH) Antagonists and |
Upcoming |
|
|
Phase III (Immunotherapy) Phase III (Immunotherapy) and Phase I (Immunotherapy) and |
Upcoming |
|
|
Phase III (Targeted Therapy) Phase III (Targeted Therapy) and Phase I (Targeted Therapy) and |
Upcoming |
|
|
Phase III (Hormonal Therapy) Phase III (Hormonal Therapy) and Phase I (Hormonal Therapy) and |
Upcoming |
12 reports |
Show
